US 8409566
Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis
granted A61KA61K2039/505A61K31/713
Quick answer
US patent 8409566 (Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis) held by Northwest Biotherapeutics, Inc. expires Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Northwest Biotherapeutics, Inc.
- Grant date
- Tue Apr 02 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K2039/505, A61K31/713, A61K38/00, A61K45/06